Captured between 2026-10-24T08:40:36.391Z and 2026-10-24T08:40:36.400Z. This is a captured core record, not a reconstruction of an arbitrary earlier moment.
Status: published
A first participant has received a vaccine in Bunia as part of the "Tumaini" clinical trial in the Democratic Republic of the Congo. The trial is evaluating candidate vaccines targeting the Bundibugyo strain of the Ebola virus. Further details regarding the scale and duration of the trial have not yet been specified.
Category: disease-outbreak · Location: Bunia
No published correction or update is recorded. This does not reconstruct changes made before correction records were kept.
Global Event Monitor. Clinical trial begins in Bunia for Bundibugyo Ebola virus vaccines. 2026-10-24T08:09:17.153Z. Status: published. urn:global-events-monitor:event:7326. https://global.eventmonitor.net/record/7326/revision/0eb380f09ba467b1a32cc85544a0e0126b3f1438a790b4c652ee065ecf608474
BibTeX · RIS · CSV · JSON · Corrections and updates · Captured versions
Current event record · Captured revision history
SHA-256: 0eb380f09ba467b1a32cc85544a0e0126b3f1438a790b4c652ee065ecf608474. A digest detects a changed payload; it is not an externally witnessed timestamp.